BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Catalyst Calendar//CN-US Event Research//ZH
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Catalyst Calendar
X-WR-CALDESC:Market-moving event research, reminders and post-event review.
BEGIN:VEVENT
UID:evt-fda-cnpv-public-meeting-june-2026@catalyst-calendar.local
DTSTAMP:20260601T102643Z
DTSTART:20260604T130000Z
DTEND:20260604T133000Z
SUMMARY:FDA Commissioner’s National Priority Voucher试点公开会议与意见征集窗口
DESCRIPTION:FDA将于2026-06-04举行CNPV试点公开会议，并接受书面意见至2026-06-29。该机制涉及超快速审评、资格标准、申请人责任、预提交要求和审评程序，可能影响罕见病、肿瘤和战略性生物医药资产的监管路径预期。\\nImpact score: 77\\nExpected: 会议和评论期可能改变市场对FDA快速审评弹性、罕见病/肿瘤资产审批周期和监管风险溢价的判断。\\nAffected: XBI(etf\, mixed\, score 76)\; IBB(etf\, mixed\, score 70)\; MRK(theme\, mixed\, score 62)\; BNTX(theme\, mixed\, score 66)\\nSources: FDA CNPV public meeting notice: https://www.fda.gov/news-events/press-announcements/fda-schedules-public-meeting-commissioners-national-priority-voucher-pilot-program\\nFDA seventh CNPV approval release: https://www.fda.gov/news-events/press-announcements/fda-grants-seventh-approval-under-national-priority-voucher-pilot-program\\nInformation only. Not investment advice.
URL:https://0.0.0.0:3000/?event=evt-fda-cnpv-public-meeting-june-2026
CATEGORIES:policy\,MACRO\,FDA\,CNPV\,regulatory\,priority review
SEQUENCE:0
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:Review catalyst preview: FDA Commissioner’s National Priority Voucher试点公开会议与意见征集窗口
END:VALARM
BEGIN:VALARM
TRIGGER:PT24H
ACTION:DISPLAY
DESCRIPTION:Complete post-event review: FDA Commissioner’s National Priority Voucher试点公开会议与意见征集窗口
END:VALARM
END:VEVENT
END:VCALENDAR